Launch week offerEnds in00h00m00s
annual Promonthly Pro
Florence Boissière-Michot
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2025
Year:
2024
Year:
2024
Year:
2023
There exists a variety of studies about tumor-infiltrating immune cells (TIICs) in cervical cancer, but their prognostic value in correlation with the histopathological subtype has never been investigated. Therefore, the aim of this study was to quantify TIICs in a panel of 238 sporadic cervical cancers and investigate the correlation with cervical cancer subtype and patient survival. TIICs levels were significantly increased in the subgroup of CSCC (191 samples) in comparison to CAC (47 samples). In CSCC, TIICs’ infiltration showed a negative correlation with age, FIGO stage and with the histone protein modification H3K4me3. Moreover, in CAC, it was positively correlated with p16 and with the glucocorticoid receptor and inversely correlated with the MDM2 protein and with H3K4me3. Interestingly, immune infiltration was an independent positive prognosticator for disease-free survival (DFS) in patients with CSCC, those bearing tumors with the strongest TIICs infiltration showing the better DFS. Altogether, the present study provides a differentiated overview of the relations between TIIC levels and prognosis in patients with CSCC vs. patients with CAC.
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (8)
Angélique Bobrie
Institut de Recherche en Cancérologie de Montpellier
Andrei Turtoi
Lab Head
Institut de Recherche en Cancérologie de Montpellier
LAURENT-MATHA Valérie
assistant professor
Institut de Recherche en Cancérologie de Montpellier
Priyanka Sharma
Team Leader
Institute of Pharmacology and Structural Biology
Vincent Cavaillès
University of Montpellier
Carl Mathis Wild
University Hospital Augsburg
aude mallavialle
Institut de Recherche en Cancérologie de Montpellier
evelyne Crapez
Head of translational Research Unit (MD, PhD)
Institut de Recherche en Cancérologie de Montpellier
Make your next move.
Prepare your application
Review drafts before you send them.